Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Minocycline"" wg kryterium: Temat


Tytuł:
Minocycline-loaded nHAP/PLGA microspheres for prevention of injury-related corneal angiogenesis.
Autorzy:
Li Z; Department of Ophthalmology, Peking University First Hospital, Beijing, 100034, People's Republic of China.; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Huang W; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Zhang M; Department of Pathology, Peking University International Hospital, Beijing, China.
Huo Y; Department of Ophthalmology, PLA Rocket Force Characteristic Medical Center, Beijing, China.
Li F; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Song L; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Wu S; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Yang Q; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Li X; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Zhang J; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China. .
Yang L; Department of Ophthalmology, Peking University First Hospital, Beijing, 100034, People's Republic of China. liu_.
Hao J; Department of Ophthalmology, Peking University First Hospital, Beijing, 100034, People's Republic of China. .
Kang L; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 28; Vol. 22 (1), pp. 134. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Minocycline*/pharmacology
Corneal Neovascularization*/drug therapy
Corneal Neovascularization*/prevention & control
Humans ; Microspheres ; Angiogenesis ; Alkalies
Czasopismo naukowe
Tytuł:
Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in Elizabethkingia anophelis .
Autorzy:
Lee CC; Clinical Medical Research Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.; Departments of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Lai CH; School of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.; Division of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.
Yang CH; Department of Biological Science and Technology, Meiho University, Pingtung 912, Taiwan.
Huang YH; School of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.; Division of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.
Lin JN; School of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.; Division of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.; Department of Critical Care Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 12; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Levofloxacin*/pharmacology
Minocycline*/pharmacology
Flavobacteriaceae*
DNA Gyrase/genetics ; Anti-Bacterial Agents/pharmacology ; Fluoroquinolones/pharmacology ; Microbial Sensitivity Tests ; Mutation ; Sulfamethoxazole ; Trimethoprim ; Drug Resistance, Bacterial/genetics
SCR Organism:
Elizabethkingia anophelis
Czasopismo naukowe
Tytuł:
Effect of minocycline, methyl prednisolone, or combination treatment on the colonic bacterial population in a state of colonic inflammation using the murine dextran sulfate sodium model.
Autorzy:
Khajah MA; College of Pharmacy, Kuwait University, PO Box 24923, 13110, Safat, Kuwait. .
Hawai S; College of Pharmacy, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.
Pokaż więcej
Źródło:
Microbial cell factories [Microb Cell Fact] 2023 Nov 10; Vol. 22 (1), pp. 232. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Minocycline*/pharmacology
Minocycline*/therapeutic use
Minocycline*/metabolism
Colitis*/drug therapy
Mice ; Animals ; Dextran Sulfate/metabolism ; Dextran Sulfate/pharmacology ; Dextran Sulfate/therapeutic use ; Methylprednisolone/metabolism ; Methylprednisolone/pharmacology ; Methylprednisolone/therapeutic use ; Colon ; Inflammation/drug therapy ; Bacteria ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Anti-Inflammatory Agents/metabolism ; Disease Models, Animal ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Mechanisms and factors affecting the removal of minocycline from aqueous solutions using graphene-modified resorcinol formaldehyde aerogels.
Autorzy:
Yazdanbakhsh A; Department of Polymer Processing, Iran Polymer and Petrochemical Institute, Tehran, Iran.
Behzadi A; Department of Polymer Processing, Iran Polymer and Petrochemical Institute, Tehran, Iran.
Moghaddam A; Department of Polymer Science, Iran Polymer and Petrochemical Institute, Tehran, Iran.
Salahshoori I; Department of Polymer Processing, Iran Polymer and Petrochemical Institute, Tehran, Iran.
Khonakdar HA; Department of Polymer Processing, Iran Polymer and Petrochemical Institute, Tehran, Iran. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 20; Vol. 13 (1), pp. 22771. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/isolation & purification
Graphite*/chemistry
Minocycline*/isolation & purification
Formaldehyde ; Resorcinols ; Water/chemistry
Czasopismo naukowe
Tytuł:
Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
Autorzy:
Li X; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Hu B; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Guan X; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Wang Z; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Zhou Y; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Sun H; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Zhang X; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Li Y; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Huang X; Basic Medical Sciences, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Zhao Y; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Wang X; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.; State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, 361102, China.
Xu H; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Zhang YW; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
Wang Z; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China. .; Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Xiamen, 361102, China. .
Zheng H; Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China. .; Basic Medical Sciences, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 May 31; Vol. 20 (1), pp. 134. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Journal Article
MeSH Terms:
Minocycline*/pharmacology
Minocycline*/therapeutic use
Leukoencephalopathies*/etiology
Leukoencephalopathies*/genetics
Male ; Animals ; Mice ; Neuroglia/metabolism ; Brain/metabolism ; Microglia/metabolism ; Receptors, Colony-Stimulating Factor/metabolism ; Receptor Protein-Tyrosine Kinases/metabolism ; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/genetics ; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/metabolism
Czasopismo naukowe
Tytuł:
Effects of minocycline on dendrites, dendritic spines, and microglia in immature mouse brains after kainic acid-induced status epilepticus.
Autorzy:
Yang X; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Li T; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Liu J; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Sun H; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Cheng L; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Song X; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Han Z; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Luo H; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Han W; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Xie L; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Jiang L; Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.; National Clinical Research Center for Child Health and Disorders, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Feb; Vol. 30 (2), pp. e14352. Date of Electronic Publication: 2023 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Kainic Acid*/toxicity
Status Epilepticus*/chemically induced
Status Epilepticus*/drug therapy
Mice ; Male ; Animals ; Microglia ; Minocycline/pharmacology ; Minocycline/therapeutic use ; Dendritic Spines/metabolism ; Hippocampus/metabolism
Czasopismo naukowe
Tytuł:
Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs.
Autorzy:
Tone M; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Iwahori K; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan. .; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, Osaka, Japan. .
Shiroyama T; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Futami S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Naito Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Fukushima K; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Miyake K; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Koyama S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Hirata H; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Nagatomo I; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Wada H; Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Takeda Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Immunopathology, World Premier International Research Center Initiative (WPI), Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan.; Center for Infectious Diseases for Education and Research (CiDER), Osaka University, Osaka, Japan.; Japan Agency for Medical Research and Development - Core Research for Evolutional Science and Technology (AMED-CREST), Osaka University, Osaka, Japan.; Center for Advanced Modalities and DDS (CAMaD), Osaka University, Osaka, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 23; Vol. 13 (1), pp. 8313. Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Minocycline*/therapeutic use
Carcinoma, Non-Small-Cell Lung*/drug therapy
Tyrosine Kinase Inhibitors*/adverse effects
Tyrosine Kinase Inhibitors*/therapeutic use
Exanthema*/chemically induced
Exanthema*/drug therapy
Humans ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Retrospective Studies ; Disease-Free Survival ; Male ; Female ; Young Adult ; Adult ; Middle Aged ; Aged ; Aged, 80 and over
Czasopismo naukowe
Tytuł:
A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
Autorzy:
Jafarzadeh A; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Pour Mohammad A; Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Khosravi M; Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Amiri S; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Rasouli A; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Keramati H; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Goodarzi A; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Mar; Vol. 30 (3), pp. e13642.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Vitiligo*/drug therapy
Vitiligo*/pathology
Hypopigmentation*
Purines*
Pyrazoles*
Sulfonamides*
Azetidines*
Thalidomide/*analogs & derivatives
Humans ; Methotrexate/therapeutic use ; Azathioprine/therapeutic use ; Mycophenolic Acid/therapeutic use ; Minocycline/therapeutic use ; Alefacept/therapeutic use ; Cyclosporine/therapeutic use ; Adrenal Cortex Hormones ; Simvastatin/therapeutic use ; Zinc/therapeutic use
Czasopismo naukowe
Tytuł:
Characterization of the Interactions between Minocycline Hydrochloride and Trypsin with Spectroscopic and Molecular Docking Technology.
Autorzy:
Wang X; School of Chemistry and Chemical Engineering, Inner Mongolia University of Science and Technology, Baotou 014010, China.; Inner Mongolia Engineering Research Center of Comprehensive Utilization of Bio-coal Chemical Industry, Baotou 014010, China.
Sun J; School of Chemistry and Chemical Engineering, Inner Mongolia University of Science and Technology, Baotou 014010, China.
Ma L; School of Chemistry and Chemical Engineering, Inner Mongolia University of Science and Technology, Baotou 014010, China.; Inner Mongolia Engineering Research Center of Comprehensive Utilization of Bio-coal Chemical Industry, Baotou 014010, China.
Nie Z; School of Life Sciences, Tsinghua University, Beijing 100084, China.
Sai H; School of Chemistry and Chemical Engineering, Inner Mongolia University of Science and Technology, Baotou 014010, China.
Cheng J; School of Chemistry and Chemical Engineering, Inner Mongolia University of Science and Technology, Baotou 014010, China.
Duan J; School of Chemistry and Chemical Engineering, Inner Mongolia University of Science and Technology, Baotou 014010, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Mar 15; Vol. 28 (6). Date of Electronic Publication: 2023 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Minocycline*
Molecular Docking Simulation ; Trypsin/chemistry ; Protein Binding ; Spectrophotometry, Ultraviolet ; Thermodynamics ; Circular Dichroism ; Spectrometry, Fluorescence ; Binding Sites
Czasopismo naukowe
Tytuł:
Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii.
Autorzy:
Lan X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.; State Key Laboratory of Drug Delivery and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, People's Republic of China.
Qin S; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Liu H; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Guo M; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Zhang Y; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Jin X; School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, China.; Shihezi University, Xinjiang, China.
Duan X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Sun M; School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, China.; Shihezi University, Xinjiang, China.
Liu Z; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Wang W; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Zheng Q; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Liao X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Chen J; State Key Laboratory of Drug Delivery and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, People's Republic of China.
Kang Y; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China. .
Xie Y; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China. .
Song X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 30; Vol. 22 (1), pp. 138. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Humans ; Tigecycline/pharmacology ; Tigecycline/therapeutic use ; Minocycline/pharmacology ; Drug Resistance, Multiple, Bacterial ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Water
Czasopismo naukowe
Tytuł:
Antidepressant-Like Effects of Edaravone and Minocycline: Investigation of Oxidative Stress, Neuroinflammation, Neurotrophic, and Apoptotic Pathways.
Autorzy:
Motafeghi F; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. .; Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran. .
Bagheri A; Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. .
Seyedabadi M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.; Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shaki F; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.; Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shokrzadeh M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. .; Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran. .
Pokaż więcej
Źródło:
Neurotoxicity research [Neurotox Res] 2022 Dec; Vol. 40 (6), pp. 1838-1858. Date of Electronic Publication: 2022 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Minocycline*/pharmacology
Minocycline*/therapeutic use
Depression*/metabolism
Rats ; Animals ; Edaravone ; Neuroinflammatory Diseases ; Corticosterone ; Maternal Deprivation ; Acetylcholinesterase/metabolism ; Antidepressive Agents/pharmacology ; Antidepressive Agents/therapeutic use ; Oxidative Stress ; Hippocampus ; Stress, Psychological/drug therapy ; Disease Models, Animal ; Behavior, Animal
Czasopismo naukowe
Tytuł:
The immunomodulatory effect of minocycline on gene expression of inflammation related cytokines in lipopolysaccharide-treated human peripheral blood mononuclear cells.
Autorzy:
Rassouli A; Pharmacology Division, Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Shihmani B; Department of Comparative Biosciences, University of Tehran, Tehran, Iran.
Mehrzad J; Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Shokrpoor S; Department of Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Pokaż więcej
Źródło:
Animal biotechnology [Anim Biotechnol] 2023 Dec; Vol. 34 (7), pp. 2159-2165. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Cytokines*/metabolism
Lipopolysaccharides*/pharmacology
Humans ; Animals ; Interleukin-10/genetics ; Leukocytes, Mononuclear ; Toll-Like Receptor 4/genetics ; Toll-Like Receptor 4/metabolism ; Minocycline/adverse effects ; Minocycline/metabolism ; Interleukin-6/genetics ; Interleukin-6/metabolism ; Interleukin-6/pharmacology ; Inflammation/chemically induced ; Inflammation/drug therapy ; Inflammation/genetics ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/metabolism ; Gene Expression
Czasopismo naukowe
Tytuł:
Exaggerated hypoxic vascular breakdown in aged brain due to reduced microglial vasculo-protection.
Autorzy:
Halder SK; San Diego Biomedical Research Institute, San Diego, California, USA.
Milner R; San Diego Biomedical Research Institute, San Diego, California, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2022 Nov; Vol. 21 (11), pp. e13720. Date of Electronic Publication: 2022 Sep 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Microglia*/metabolism
Minocycline*/pharmacology
Aged ; Humans ; Animals ; Mice ; Brain/metabolism ; Blood-Brain Barrier/metabolism ; Hypoxia/metabolism
Czasopismo naukowe
Tytuł:
A randomized, controlled trial of intense pulsed light in combination with minocycline hydrochloride for the treatment of inflammatory acne vulgaris.
Autorzy:
Qu H; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Wang Y; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Yang F; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Wang G; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Gao L; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Li K; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2022 Aug; Vol. 21 (8), pp. 3386-3392. Date of Electronic Publication: 2022 May 16.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Acne Vulgaris*/drug therapy
Acne Vulgaris*/pathology
Minocycline*/adverse effects
Combined Modality Therapy ; Humans ; Immunoglobulin A/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
2023 Korean sexually transmitted infections treatment guidelines for Mycoplasma genitalium by KAUTII.
Autorzy:
Lee SJ; Department of Urology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Choi JB; Department of Urology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Bae S; Department of Urology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Na SW; Department of Urology, Gwangju Veterans Hospital, Gwangju, Korea.
Jung HD; Department of Urology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
Jung HJ; Department of Urology, Daegu Catholic University Medical Center, Daegu, Korea.
Jung SI; Department of Urology, Chonnam National University Medical School, Hwasun, Korea.
Song PH; Department of Urology, Yeungnam University College of Medicine, Daegu, Korea.
Lee G; Department of Urology, Dankook University College of Medicine, Cheonan, Korea. .
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2024 Jan; Vol. 65 (1), pp. 16-22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mycoplasma genitalium*
Mycoplasma Infections*/drug therapy
Sexually Transmitted Diseases*/drug therapy
Humans ; Anti-Bacterial Agents/therapeutic use ; Azithromycin/therapeutic use ; Macrolides/therapeutic use ; Doxycycline/therapeutic use ; Drug Resistance, Bacterial ; Minocycline/therapeutic use ; Republic of Korea/epidemiology
Czasopismo naukowe
Tytuł:
Minocycline-induced Hyperpigmentation Confined to Lupus Miliaris Disseminatus Faciei.
Autorzy:
Kakurai M; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan.
Honda R; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan. .
Miyahara H; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan.
Ito S; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan.
Pokaż więcej
Źródło:
Acta dermato-venereologica [Acta Derm Venereol] 2023 Dec 07; Vol. 103, pp. adv18462. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Rosacea*/chemically induced
Rosacea*/diagnosis
Rosacea*/drug therapy
Hyperpigmentation*/chemically induced
Hyperpigmentation*/diagnosis
Facial Dermatoses*/chemically induced
Facial Dermatoses*/diagnosis
Facial Dermatoses*/drug therapy
Lupus Vulgaris*
Humans ; Minocycline/adverse effects
Czasopismo naukowe
Tytuł:
Pemphigus foliaceus treated with minocycline monotherapy or low-dose prednisolone combination therapy.
Autorzy:
Fan B; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Chen X; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Zhu X; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Wang M; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2113756. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Prednisolone*/therapeutic use
Pemphigus*/drug therapy
Humans ; Minocycline/therapeutic use ; Glucocorticoids/therapeutic use ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units.
Autorzy:
Bai XR; Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, No. 45 Changchun Street, Xi Cheng District, Beijing, 100053, China.
Wang ZZ; Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, No. 45 Changchun Street, Xi Cheng District, Beijing, 100053, China.
Li WC; Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, No. 45 Changchun Street, Xi Cheng District, Beijing, 100053, China.
Wang YG; Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, No. 45 Changchun Street, Xi Cheng District, Beijing, 100053, China.
Lou R; Department of Intensive Medicine, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, Beijing, 100053, China.
Qu X; Intensive Care Unit, Department of Neurosurgery, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, Beijing, 100053, China.
Fan L; Neurology Intensive Care Unit, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, Beijing, 100053, China.
Zhang W; Department of Pulmonary and Critical Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, 100053, China.
Wu YC; Central Laboratory of Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Yan SY; Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, No. 45 Changchun Street, Xi Cheng District, Beijing, 100053, China.
Zhang L; Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, No. 45 Changchun Street, Xi Cheng District, Beijing, 100053, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Nov 27; Vol. 23 (1), pp. 830. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumonia, Bacterial*/drug therapy
Acinetobacter baumannii*
Humans ; Tigecycline/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/pharmacology ; Carbapenems/therapeutic use ; Carbapenems/pharmacology ; Drug Monitoring ; Retrospective Studies ; Treatment Outcome ; Gram-Negative Bacteria ; Intensive Care Units ; Fibrinogen ; Drug Resistance, Multiple, Bacterial ; Minocycline/therapeutic use
Czasopismo naukowe
Tytuł:
Effect of Locally Delivered Minocycline on the Profile of Subgingival Bacterial Genera in Patients with Periodontitis: A Prospective Pilot Study.
Autorzy:
Morozumi T; Department of Periodontology, Faculty of Dentistry, Kanagawa Dental University, 82 Inaoka-cho, Yokosuka 238-8580, Japan.
Nakayama Y; Departments of Periodontology and Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo, 2-870-1 Sakaecho-nishi, Matsudo 271-8587, Japan.
Shirakawa S; Department of Dental Hygiene, Tsurumi Junior College, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.
Imamura K; Department of Periodontology, Tokyo Dental College, 2-9-18 Kanda-Misakicho, Chiyoda-ku, Tokyo 101-0061, Japan.
Nohno K; Division of Oral Science for Health Promotion, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan.
Nagano T; Department of Periodontology, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.
Miyazawa H; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan.
Hokari T; Division of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan.
Takuma R; Department of Periodontology, Faculty of Dentistry, Kanagawa Dental University, 82 Inaoka-cho, Yokosuka 238-8580, Japan.
Sugihara S; Department of Periodontology, Faculty of Dentistry, Kanagawa Dental University, 82 Inaoka-cho, Yokosuka 238-8580, Japan.
Gomi K; Department of Periodontology, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.
Saito A; Department of Periodontology, Tokyo Dental College, 2-9-18 Kanda-Misakicho, Chiyoda-ku, Tokyo 101-0061, Japan.
Ogata Y; Departments of Periodontology and Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo, 2-870-1 Sakaecho-nishi, Matsudo 271-8587, Japan.
Komaki M; Department of Periodontology, Faculty of Dentistry, Kanagawa Dental University, 82 Inaoka-cho, Yokosuka 238-8580, Japan.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2022 May 18; Vol. 12 (5). Date of Electronic Publication: 2022 May 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Minocycline*/pharmacology
Minocycline*/therapeutic use
Periodontitis*/drug therapy
Humans ; Pilot Projects ; Prospective Studies ; Root Planing
Czasopismo naukowe
Tytuł:
No increased rate of cyclops lesions and extension deficits after remnant-preserving ACL reconstruction using the sparing technique.
Autorzy:
Bierke S; Department of Orthopedic and Trauma Surgery, Martin Luther Hospital, Caspar Theys Strasse 27-31, 14 193, Berlin, Germany.
Häner M; Department of Orthopedic and Trauma Surgery, Martin Luther Hospital, Caspar Theys Strasse 27-31, 14 193, Berlin, Germany.
Karpinski K; Department of Orthopedic and Trauma Surgery, Martin Luther Hospital, Caspar Theys Strasse 27-31, 14 193, Berlin, Germany.
Hees T; Department of Orthopedic and Trauma Surgery, Martin Luther Hospital, Caspar Theys Strasse 27-31, 14 193, Berlin, Germany.
Petersen W; Department of Orthopedic and Trauma Surgery, Martin Luther Hospital, Caspar Theys Strasse 27-31, 14 193, Berlin, Germany. .
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2022 Oct 21; Vol. 17 (1), pp. 463. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Anterior Cruciate Ligament*/surgery
Anterior Cruciate Ligament*/pathology
Minocycline*
Humans ; Prospective Studies ; Treatment Outcome ; Pain/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies